Sangeeta Goswami, MD, PhD profile page

Dr. Sangeeta Goswami is a physician-scientist at the Department of Genitourinary Medical Oncology and the Department of Immunology, Division of Cancer Medicine, at the University of Texas MD Anderson Cancer Center in Houston, Texas. She obtained her medical degree from Gauhati Medical College in Assam, India, and earned a PhD in Immunology from the Baylor College of Medicine in Houston. Dr. Goswami completed her Internal Medicine Residency at the University of Pittsburgh Medical Center (UPMC) and a Medical Oncology Fellowship at MD Anderson Cancer Center. A dedicated researcher and clinician, Dr. Goswami has published numerous original research articles and reviews in top-tier journals such as Nature Medicine, Nature Immunology, Science, Nature Reviews Immunology, and Science Translational Medicine. Her research has significantly contributed to the development of novel combination immunotherapies for cancer patients. Her clinical focus is on treating patients with renal cell carcinoma and urothelial carcinoma, while her laboratory in the Department of Immunology investigates the cellular dynamics of the tumor-immune ecosystem and its influence on immune checkpoint therapy responses. Dr. Goswami has also designed and is leading several investigator-initiated clinical trials based on her pre-clinical findings. Dr. Goswami was recently elected to the “Extended Leadership Team” for the Break Through Cancer (BTC) GBM team, a collaborative research initiative between MD Anderson, Dana Farber Cancer Institute, MIT, Johns Hopkins, and Memorial Sloan Kettering Cancer Center. In this role, she leads discovery science on myeloid cell biology to explore new therapeutic approaches for glioblastoma. She has received several accolades for her work, including the Andrew Sabin Award in 2021 for high-risk, high-impact research for emerging leaders.